Related Experiment Video
Updated: May 26, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Tablet- and Group-Based Multicomponent Cognitive Stimulation for Older Adults With Mild Cognitive Impairment:
Khanitin Jornkokgoud1,2, Pattrawadee Makmee3, Peera Wongupparaj4
1College of Research Methodology and Cognitive Science, Burapha University, Chon Buri, Thailand.
Tablet-based multicomponent cognitive stimulation therapy (MCST) significantly improved cognition and reduced depression and anxiety in older adults with mild cognitive impairment (MCI). This technology-enhanced intervention shows promise for mental health professionals working with MCI populations.
Area of Science:
- Gerontology
- Neuroscience
- Psychiatry
Background:
- Cognitive Stimulation Therapy (CST) is a group intervention for dementia and mild cognitive impairment (MCI) that enhances cognition and quality of life.
- Previous research suggests that incorporating technological devices into group interventions may offer additional benefits.
Purpose of the Study:
- To assess the effectiveness of a tablet- and group-based multicomponent cognitive stimulation therapy (MCST) for improving cognitive functions in older adults with MCI.
- To report the protocol for a trial evaluating the impact of the MCST program on individuals with MCI.
Main Methods:
- A pilot study involved 30 individuals with MCI participating in 10 sessions of tablet- and group-based MCST.
- A subsequent randomized controlled trial will compare tablet-based MCST, tablet-based CST, and control groups among 93 individuals with MCI from semiurban communities.
- Assessments include pre- and posttest evaluations with computer-based neuropsychological tests and electroencephalography to analyze cognitive, behavioral, and emotional effects.
Main Results:
- The pilot study demonstrated significant improvements in cognition (P<.001), reduced depression (P=.002), and decreased anxiety (P=.001) post-intervention.
- Quality of life did not show significant changes (P=.18).
- The randomized controlled trial is underway, with data analysis initiated and results anticipated by mid- to late-2025.
Conclusions:
- This study represents the first tablet-group-based MCST for older adults with MCI in middle-income countries.
- It aims to elucidate the neuropsychological underpinnings of observed positive outcomes through detailed data analysis.
- The findings will provide valuable knowledge and guidance for mental health professionals implementing MCST for MCI populations.
Related Concept Videos
Cognitive Development During Adulthood
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

